Centre for Protein Science and Crystallography, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.
Toxins (Basel). 2022 Jun 6;14(6):392. doi: 10.3390/toxins14060392.
VVA2 (volvatoxin A chain 2) is a cardiotoxic protein purified from . Its biological activities include hemolysis, writhing reaction, neurotoxicity, and ventricular systolic arresting activity. The cytotoxicity of VVA2 was mainly considered due to its pore-forming activity. Here we report a novel biological activity of its variants VVA2 I82E/K86K as a duplex-specific nuclease. Recombinant VVA2 variant I82E/L86K (Re-VVA2 I82E/L86K), deprived of the oligomerization property, shows increased nuclease activity compared to VVA2. Re-VVA2 I82E/L86K converts supercoiled DNA (Replicative form I, RF I) into nicked form (RF II) and linear form (RF III) in the presence of Mg or Mn. Besides plasmid DNA, it also exhibits nuclease activity on genomic DNA rather than ssDNA or RNA. Re-VVA2 I82E/L86K preferentially cleaves dG-dC-rich dsDNA regions and shows the best performance at pH 6-9 and 55 °C. Our structure-function study has revealed amino acid E111 may take an active part in nuclease activity through interacting with metal ions. Based on the sequences of its cleavage sites, a "double-hit" mechanism was thereby proposed. Given that Re-VVA2 I82E/L86K did not exhibit the conserved nuclease structure and sequence, it is considered an atypical duplex-specific nuclease.
VVA2(volvatoxin A 链 2)是一种从. 中纯化得到的心脏毒性蛋白。其生物学活性包括溶血、扭体反应、神经毒性和心室收缩性抑制活性。VVA2 的细胞毒性主要归因于其形成孔的活性。在此,我们报告了其变体 VVA2 I82E/K86K 的一种新的生物学活性,作为一种双链特异性核酸内切酶。缺乏寡聚化特性的重组 VVA2 变体 I82E/L86K(Re-VVA2 I82E/L86K)显示出比 VVA2 更高的核酸酶活性。Re-VVA2 I82E/L86K 在 Mg 或 Mn 存在下将超螺旋 DNA(复制形式 I,RF I)转化为缺口形式(RF II)和线性形式(RF III)。除了质粒 DNA 外,它还对基因组 DNA 表现出核酸酶活性,而不是 ssDNA 或 RNA。Re-VVA2 I82E/L86K 优先切割 dG-dC 丰富的双链 DNA 区域,并在 pH 6-9 和 55°C 下表现出最佳性能。我们的结构功能研究表明,氨基酸 E111 可能通过与金属离子相互作用积极参与核酸酶活性。基于其切割位点的序列,提出了一种“双打击”机制。鉴于 Re-VVA2 I82E/L86K 不表现出保守的核酸酶结构和序列,它被认为是一种非典型的双链特异性核酸内切酶。